US 2006/150283

a) a full length cDNA nucleic acid having a nucleotide sequence which encodes an amino acid sequence exhibiting at least 40% sequence identity to an amino acid sequence encoded by

(1) a full length cDNA nucleotide sequence described in the Seqeuence Listing or the Sequence Listing-Miscellaneous Feature documents, or a fragment thereof; or

(2) a complement of a full-length cDNA nucleotide sequence shown in the Seqeuence Listing or the Sequence Listing-Miscellaneous Feature documents, or a fragment thereof;

b) a nucleic acid which is the reverse of the nucleotide sequence according to subparagraph (a), such that the reverse nucleotide sequence has a sequence order which is the reverse of the sequence order of the nucleotide sequence according to subparagraph (a);

c) a nucleic acid capable of hybridizing to a nucleic acid having a sequence selected from the group consisting of:

a full-length cDNA nucleotide sequence which is shown in the Seqeuence Listing or the Sequence Listing-Miscellaneous Feature documents; and

a nucleotide sequence which is complementary to a full-length cDNA nucleotide sequence shown in the Seqeuence Listing or the Sequence Listing-Miscellaneous Feature documents, under conditions that permit formation of a nucleic acid duplex at a temperature from about 40° C and 48° C below the melting temperature of the nucleic acid duplex, with the proviso that said nucleotide sequence is not any of the sequences described in the Tables of any of Patent Publication Nos. WO 200040695, CA 2300692 A1, EP 1033405 A2, CA 2302828 A1 and EP 1059354 A2 and any proteins listed in the application that are identified by gi number or otherwise as being from the non-redundant GenBank CDS translations or Protein Database (PDB), available via the internet, or (PIR-International) Database (PIR), available via the internet.